Surprisingly, serum-stimulated LN-229 and T98G cells were both resistant to small molecular weight IGF-IR inhibitor, NVP-AEW541, which effectively inhibited growth and survival of several other tumor cell lines including Medulloblastoma, colon and prostate cancer [36,42,43]. This evidence concerns the gene IGF1R and neoplasm.